Last data update: Jun 03, 2024. (Total: 46935 publications since 2009)
Records 1-4 (of 4 Records) |
Query Trace: Ketgudee L [original query] |
---|
Cost assessment of a program for laboratory testing of plasma trans-fatty acids in Thailand
Datta BK , Aekplakorn W , Chittamma A , Meemeaw P , Vesper H , Kuiper HC , Steele L , Cobb LK , Li C , Husain MJ , Ketgudee L , Kostova D , Richter P . Public Health Pract (Oxf) 2021 2 100199 Objectives: Intake of trans fatty acids (TFA) increases the risk of cardiovascular disease. Assessment of TFA exposure in the population is key for determining TFA burden and monitoring change over time. One approach for TFA monitoring is measurement of TFA levels in plasma. Understanding costs associated with this approach can facilitate program planning, implementation and scale-up. This report provides an assessment of costs associated with a pilot program to measure plasma TFA levels in Thailand. Study design: Cost analysis in a laboratory facility in Thailand. Methods: We defined three broad cost modules: laboratory, personnel, and facility costs, which were further classified into sub-components and into fixed and variable categories. Costs were estimated based on the number of processed plasma samples (100–2700 in increments of 50) per year over a certain number of years (1–5), in both USD and Thai Baht. Total cost and average costs per sample were estimated across a range of samples processed. Results: The average cost per sample of analyzing 900 samples annually over 5 years was estimated at USD186. Laboratory, personnel, and facility costs constitute 67%, 23%, and 10% of costs, respectively. The breakdown across fixed costs, such as laboratory instruments and personnel, and variable costs, such as chemical supplies, was 60% and 40%, respectively. Average costs decline as more samples are processed: the cost per sample for analyzing 100, 500, 1500, and 2500 samples per year over 5 years is USD1351, USD301, USD195; and USD177, respectively. Conclusions: Laboratory analysis of plasma TFA levels has high potential for economies of scale, encouraging a long-term approach to TFA monitoring initiatives, particularly in countries that already maintain national biometric repositories. © 2021 The Authors |
Assessing costs of a hypertension management program: An application of the HEARTS costing tool in a program planning workshop in Thailand
Husain MJ , Allaire BT , Hutchinson B , Ketgudee L , Srisuthisak S , Yueayai K , Pisitpayat N , Nugent R , Datta BK , Joseph KT , Kostova D . J Clin Hypertens (Greenwich) 2019 22 (1) 111-117 The HEARTS technical package, a part of the Global Hearts Initiative to improve cardiovascular health globally, is a strategic approach for cardiovascular disease prevention and control at the primary care level. To support the evaluation of costs associated with HEARTS program components, a costing tool was developed to evaluate the incremental cost of program implementation. This report documents an application of the HEARTS costing tool during a costing workshop prior to the initiation of a HEARTS pilot program in Thailand's Phothong District, 2019-2020. During the workshop, a mock exercise was conducted to estimate the expected costs of the pilot study. The workshop application of the tool underscored its applicability to the HEARTS program planning process by identifying cost drivers associated with individual program elements. It further illustrated that by supporting disaggregation of costs into fixed and variable categories, the tool can inform the scalability of pilot projects to larger populations. Lessons learned during the initial development and application of the costing tool can inform future HEARTS evaluation efforts. |
Evaluation of a hospital-based injury surveillance system for monitoring road traffic deaths in Phuket, Thailand
Nittayasoot N , Peterson AB , Thammawijaya P , Parker EM , Sathawornwiwat A , Boonthanapat N , Chantian T , Voradetwitaya L , Jiraphongsa C , Sagarasaeranee O , Sansilapin C , Rattanathamsakul T , Ketgudee L , Tantiworrawit P . Traffic Inj Prev 2019 20 (4) 1-7 OBJECTIVES: The objective of this study was to evaluate and injury surveillance (IS) system's ability to monitor road traffic deaths and the coverage of road traffic injury and death surveillance in Phuket, Thailand. METHODS: U.S. Centers for Disease Control and Prevention guidelines on surveillance system evaluation were used to qualitatively and quantitatively evaluate IS. Interviews with key stakeholders focused on IS's usefulness, simplicity, flexibility, acceptability, and stability. Active case finding of 2014 road traffic deaths in all paper and electronic hospital record systems was used to assess system sensitivity, positive predictive value, and data quality. Electronic data matching software was used to determine the implications of combining IS data with other provincial-level data sources (e.g., death certificates, electronic vehicle insurance claim system). RESULTS: Evaluation results indicated that IS was useful, flexible, acceptable, and stable, with a high positive predictive value (99%). Simplicity was limited due to the burden of collecting data on all injuries and use of paper-based data collection forms. Sensitivity was low, with IS only identifying 55% of hospital road traffic death cases identified during active case finding; however, IS cases were representative of cases identified. Data accuracy and completeness varied across data fields. Combining IS with active case finding, death certificates, and the electronic vehicle insurance claim system more than doubled the number of road traffic death cases identified in Phuket. CONCLUSION: An efficient and comprehensive road traffic injury and death surveillance system is critical for monitoring Phuket's road traffic burden. The hospital-based IS system is a useful system for monitoring road traffic deaths and assessing risk behaviors. However, the complexity of data collection and limited coverage hinders the ability of IS to fully represent road traffic deaths in Phuket Province. Combining data sources could improve coverage and should be considered. |
Challenges in educating women about human papillomavirus (HPV) and HPV screening test results: Experience from an HPV demonstration project in North-Eastern Thailand
Senkomago V , Sangrajrang S , Ketgudee L , Saraiya M . Papillomavirus Res 2016 2 190-192 Research advances have identified persistent high-risk human papillomavirus (HPV) infections as the cause of almost all cervical cancers, and allowed for the development of several HPV tests to screen for precancerous cervical lesions [1]. The World Health Organization released new cervical cancer screening guidelines in 2013, recommending the use of primary HPV testing as the preferred screening method in areas where high quality cytology-based screening programs do not already exist [2]. The incorporation of HPV tests for cervical cancer screening has several benefits: i) they have higher sensitivity than Pap tests for the detection of precancerous cervical lesions [3]; ii) HPV tests have a high negative predictive value that could enable programs to extend screening intervals [4]; iii) some HPV tests can be processed on the same day to provide rapid results and quick treatment, if needed [5]; and iv) HPV testing also allows for the possibility of self-collection of samples by women which can increase screening coverage in hard-to-reach populations or in areas with limited health professionals [6]. As cervical cancer screening programs incorporate HPV tests for primary screening, there is a need to examine HPV knowledge in women to evaluate and inform HPV education efforts. | As part of the demonstration project investigating the efficacy of primary HPV testing for cervical cancer screening in Northern Thailand described in a manuscript this issue, “Comparative accuracy of Pap smear and HPV screening using COBAS Test in Ubon Ratchathani in Thailand,” we examined HPV knowledge and attitudes toward HPV test results among Thai women. Prior to the start of the project, all the participating doctors and nurses attended a three-day workshop on HPV infection, HPV screening tests, communication of HPV test results, and study procedures of the project. Women aged 30–60 years, who were attending primary healthcare centers in Ubon Ratchathani province for routine cervical cancer screening with a Pap test, were eligible to participate in the project and receive primary HPV testing concurrently. Women who agreed to participate in the project provided consent, after which nurses at the health centers briefly educated each woman about cervical cancer and screening with high-risk HPV tests. This demonstration was approved by the ethics committee of the National Cancer Institute, Bangkok, Thailand. |
- Page last reviewed:Feb 1, 2024
- Page last updated:Jun 03, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure